Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Work In Process (2016 - 2022)

Biomerica's Work In Process history spans 11 years, with the latest figure at $714000.0 for Q1 2022.

  • On a quarterly basis, Work In Process fell 27.81% to $714000.0 in Q1 2022 year-over-year; TTM through Feb 2022 was $714000.0, a 27.81% decrease, with the full-year FY2021 number at $1.0 million, up 1.82% from a year prior.
  • Work In Process hit $714000.0 in Q1 2022 for Biomerica, up from $708000.0 in the prior quarter.
  • Over the last five years, Work In Process for BMRA hit a ceiling of $1.5 million in Q4 2020 and a floor of $708000.0 in Q4 2021.
  • Historically, Work In Process has averaged $904625.0 across 5 years, with a median of $872000.0 in 2018.
  • Biggest five-year swings in Work In Process: surged 81.56% in 2020 and later crashed 53.3% in 2021.
  • Tracing BMRA's Work In Process over 5 years: stood at $791000.0 in 2018, then rose by 5.56% to $835000.0 in 2019, then surged by 81.56% to $1.5 million in 2020, then crashed by 53.3% to $708000.0 in 2021, then increased by 0.85% to $714000.0 in 2022.
  • Business Quant data shows Work In Process for BMRA at $714000.0 in Q1 2022, $708000.0 in Q4 2021, and $926000.0 in Q3 2021.